VNME:NASDAQVendome Acquisition Corporation I Analysis
Data as of 2026-06-14 - not real-time
$10.22
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Vendome Acquisition Corp. I trades at $10.22, a price that translates to an eye‑watering price‑to‑book ratio of 639, reflecting a market that is pricing in a speculative merger rather than any underlying earnings. Technicals show a modest bullish bias — the 20‑day SMA (10.19) sits just above the 50‑day (10.15) and 200‑day (10.06) averages — but momentum indicators are mixed: RSI is at 68, nudging toward overbought, while the MACD histogram has turned negative and the signal line is labeled “bearish.” Volume has been sharply declining, with today’s trade count at 142 versus a 10‑day average of over 11,000, underscoring thin liquidity. The broader market sentiment is in “Extreme Greed” mode, yet the SPAC’s lack of revenue, negative operating cash flow, and zero earnings make the valuation appear severely stretched.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- RSI approaching overbought levels
- Bearish MACD signal despite bullish SMA alignment
- Sharp decline in trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Absence of revenue or earnings
- Speculative nature of SPAC merger outcomes
- Extremely high price‑to‑book ratio
Long Term
> 3 yearsCautious
Model confidence: 3/10
Key Factors
- No operating business and negative cash flow
- Risk of merger failure or dilution
- Persistently high valuation without fundamentals
Key Metrics & Analysis
Financial Health
P/B Ratio638.8
Op. Cash Flow$-858557
Industry P/E16.8
Technical Analysis
TrendBullish
RSI67.5
Support$10.16
Resistance$10.22
MA 20$10.19
MA 50$10.15
MA 200$10.06
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta-0.01
Volatility1.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.